Breast Cancer Clinical Trials in Philadelphia

Showing 361-380 of 391 trials

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

NCT00082095

The main purpose of this study is to compare treatment with either pegylated liposomal doxorubicin or capecitabine as first line chemotherapy for metastatic breast cancer in women 60 years and older.

Metastatic Breast Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.62 participantsStarted Apr 2004

Fountain Valley, California, United States • Oxnard, California, United States • Soquel, California, United States +24 more locations

COMPLETEDPHASE2< 1 mile

Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer

NCT00615940

This randomized, double-blind, placebo controlled phase II trial is studying how well capecitabine works when given in combination with WX-671 or when given alone in treating patients receiving first-line therapy for her2negative metastatic breast cancer.

Metastatic Breast Cancer

Heidelberg Pharma AG132 participantsStarted Jul 2008

New York, New York, United States • Cleveland, Ohio, United States • Philadelphia, Pennsylvania, United States +17 more locations

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer

Breast Cancer Trials in Other Cities

Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer

Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer

Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer

Nutrition Intervention in Treating Women With Breast Cancer

Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer

Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

Other Conditions in Philadelphia